The Insulin Affordability Crisis: A Policy Proposal to Protect Minnesotans

  • Keelia Silvis Public Health Administration and Policy, School of Public Health, University of Minnesota, Minneapolis, MN
  • Mary Gilbertson Public Health Administration and Policy, School of Public Health, University of Minnesota, Minneapolis, MN
  • Yanyan Chen Public Health Nutrition, School of Public Health, University of Minnesota, Minneapolis, MN
  • Jose Huape Public Health Administration and Policy, School of Public Health, University of Minnesota, Minneapolis, MN
  • David Marshall Public Health Practice, School of Public Health, University of Minnesota, Minneapolis, MN, University of Wisconsin School of Medicine and Public Health, Madison, WI

Abstract

The increasing prevalence of diabetes mellitus creates serious economic and health burdens for the state of Minnesota, which have been exacerbated by rising insulin prices. Factors contributing to cost increases include the controversial negotiations between pharmaceutical manufacturers and insurance companies, the lack of price transparency, and the scarcity of generic insulin options. This proposal recommends that Minnesota Legislature create a Prescription Drug Cost Review Board and Stakeholder Advisory Council to monitor drug prices and set statewide upper payment limits. This policy will protect Minnesotans from the undue burden of rising medication costs.

Section
Policy Proposals